Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Type of study
Publication year range
1.
Tsitologiia ; 57(3): 184-91, 2015.
Article in Russian | MEDLINE | ID: mdl-26021167

ABSTRACT

Mitochondria are dynamic organelles whose homeostasis is defined by two opposite processes: fission (or fragmentation), or fusion. Fission of mitochondria results in generation of smaller organelles and fusion is when they produce tubular or net-like structures. Although a number of proteins are already known to control the process of fission/fusion additional regulators controlling these processes are being found. The Bcl-2 family members take part in the regulation of apoptosis and according to the current view are involved in the mitochondrial net-like structure maintenance. In this review we will discuss mechanisms of mitochondrial fission/fusion regulation and summarize the available information on the role of Bcl-2 family members in the regulation of mitochondrial fission/fusion dynamics.


Subject(s)
Apoptosis/genetics , Mitochondrial Dynamics/genetics , Mitochondrial Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , Animals , Eukaryotic Cells/metabolism , Eukaryotic Cells/pathology , Gene Expression Regulation , Humans , Mitochondria/chemistry , Mitochondria/metabolism , Mitochondrial Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction
2.
Biochemistry (Mosc) ; 80(2): 127-44, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25756529

ABSTRACT

Recently, AMP-activated protein kinase (AMPK) has emerged as a key regulator of energy balance at cellular and whole-body levels. Due to the involvement in multiple signaling pathways, AMPK efficiently controls ATP-consuming/ATP-generating processes to maintain energy homeostasis under stress conditions. Loss of the kinase activity or attenuation of its expression leads to a variety of metabolic disorders and increases cancer risk. In this review, we discuss recent findings on the structure of AMPK, its activation mechanisms, as well as the consequences of its targets in regulation of metabolism. Particular attention is given to low-molecular-weight compounds that activate or inhibit AMPK; the perspective of therapeutic use of such modulators in treatment of several common diseases is discussed.


Subject(s)
AMP-Activated Protein Kinases/chemistry , AMP-Activated Protein Kinases/physiology , AMP-Activated Protein Kinases/genetics , Allosteric Regulation , Energy Metabolism , Enzyme Activation , Eukaryota/enzymology , Gene Expression , Humans , Metabolic Diseases/enzymology , Metabolic Diseases/etiology , Metabolic Diseases/genetics , Neoplasms/enzymology , Neoplasms/genetics , Protein Conformation , Signal Transduction
3.
Tsitologiia ; 56(3): 241-7, 2014.
Article in Russian | MEDLINE | ID: mdl-25509421

ABSTRACT

Influenza is a respiratory infection widely spread around the world. Influenza complications are various in nature and in most cases involve the excessive proliferation of cells in respiratory tract as a factor of pathogenesis. In the present work the efficacy of the use of apoptosis inducer 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalenecarboxylic acid (AHPN) for prophylaxis of chronic damage on the stage of post- influenza pneumonia has been studied. Mice were infected with influenza virus A/mallard/Pennsylvania/10218/84(H5N2) with further study of the level of influenza virus reproduction in the lungs, specific mortality of animals and morphology of the foci of post-influenza pneumonia on the 15th day post inoculation. AHPN was shown to decrease the infectious activity of the virus in the lungs by 1.2-1.5 log10 EID50/0.2 mL depending on the dose as compared to the control group, in a weak decrease in mortality of animals (protection index was 12.5-37.5%). The application of AHPN restricted both the proliferative and infiltrative component in chronic post-influenza lesions. It demonstrated the most pronounced effect on the lung morphology when applied on days 4 to 7 post inoculation, i. e. in the period of maximal activation of inflammatory tissue infiltration and regeneration of bronchiolar epithelium. In conclusion, the use of apoptosis inducers can partially prevent the development of chronic post-influenza lesions with proliferative component.


Subject(s)
Antineoplastic Agents/pharmacology , Epithelial Cells/drug effects , Lung/drug effects , Orthomyxoviridae Infections/drug therapy , Pneumonia, Viral/drug therapy , Respiratory Mucosa/drug effects , Retinoids/pharmacology , Animals , Apoptosis/drug effects , Cell Proliferation , Dose-Response Relationship, Drug , Epithelial Cells/pathology , Epithelial Cells/virology , Influenza A Virus, H5N2 Subtype/drug effects , Influenza A Virus, H5N2 Subtype/growth & development , Lung/pathology , Lung/virology , Mice , Orthomyxoviridae Infections/complications , Orthomyxoviridae Infections/mortality , Orthomyxoviridae Infections/pathology , Pneumonia, Viral/etiology , Pneumonia, Viral/mortality , Pneumonia, Viral/pathology , Respiratory Mucosa/pathology , Respiratory Mucosa/virology , Survival Analysis , Time Factors , Viral Load/drug effects , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL